Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Cerilliant
Chinese Patent Office
Cantor Fitzgerald
Teva
Argus Health
Mallinckrodt
UBS
Deloitte

Generated: June 19, 2018

DrugPatentWatch Database Preview

Tentative Approvals for: galantamine hydrobromide

« Back to Dashboard

galantamine hydrobromide Drugs with Tentative Approvals

Applicant Generic Name NDA Strength Dosage Form
Sun Pharm Inds galantamine hydrobromide 077592 4MG TABLET; ORAL
Watson Labs galantamine hydrobromide 077767 EQ 4MG BASE TABLET; ORAL
Ranbaxy galantamine hydrobromide 077588 4MG TABLET; ORAL
Sun Pharm Inds galantamine hydrobromide 077592 12MG TABLET; ORAL
Applicant Generic Name NDA Strength Dosage Form

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Fish and Richardson
Baxter
Healthtrust
Argus Health
Dow
Fuji
Johnson and Johnson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.